Here are just a few of the incredible people at the Knight Cancer Institute working to transform cancer science, early detection and the future of patient care. Read the full story.
Xubo Song, Ph.D.
Joined OHSU from California Institute of Technology
Scientific co-director of the Center for Biomedical Data Science and professor at the Division of Oncological Sciences, the Department of Medical Informatics and Clinical Epidemiology and the Department of Biomedical Engineering.
Song specializes in machine learning and AI, applying them to biomedical data, especially images focusing on cancer research. A past project of hers was the study of dynamic contrast-enhanced MRI images to predict chemotherapy responses for breast cancer. Currently, she’s using AI to integrate MRI, pathology and molecular imaging for prostate cancer patients’ outcome predictions.
Advancements in AI have empowered Song’s studies, allowing for more accurate data analyses — which in turn support physician decisions and enable precision patient care.
The Center for Biomedical Data Science, co-directed by Song, was fueled by a $10 million gift from Mary and Tim Boyle in 2020.
“We now have deeper measurements, richer data, and that, coupled with the advancement of the AI, provides powerful tools. The measurement advancements give me much more data. We can now measure millions, even billions of cells, and acquire millions of images, which need to be quantified and analyzed. Now we have the tools, the algorithms, in deep learning and AI, that allow us to understand this rich data.”
